ALGOPYRIN Trademark

Trademark Overview


On Tuesday, June 17, 2025, a trademark application was filed for ALGOPYRIN with the United States Patent and Trademark Office. The USPTO has given the ALGOPYRIN trademark a serial number of 79428779. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, February 3, 2026. This trademark is owned by Opella Healthcare Hungary Kft.. The ALGOPYRIN trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical products
algopyrin

General Information


Serial Number79428779
Word MarkALGOPYRIN
Filing DateTuesday, June 17, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateTuesday, February 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHuman pharmaceutical products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 5, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOpella Healthcare Hungary Kft.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHU

Trademark Events


Event DateEvent Description
Thursday, July 24, 2025SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, August 5, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, January 28, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 28, 2026APPLICATION FILING RECEIPT MAILED
Thursday, January 29, 2026ASSIGNED TO EXAMINER
Tuesday, February 3, 2026NON-FINAL ACTION WRITTEN
Wednesday, February 4, 2026NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW